Loading…

Analysis of the 5‐HT receptors mediating contractions in the rabbit isolated renal artery

1 Using a number of agonist and antagonist compounds, we have attempted to characterize the responses and receptors involved in the effects of 5‐hydroxytryptamine (5‐HT) in the rabbit isolated renal artery. 2 In vessel segments precontracted with the thromboxane‐mimetic agent, U46619 (100 nm), neith...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 1991-12, Vol.104 (4), p.887-894
Main Authors: Tadipatri, Sreekanth, Heuven‐Nolsen, Dicky, Feniuk, Wasyl, Saxena, Pramod R.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5732-9071daea1212fa7dcbf23baad19b71e03e36225337cbd6202d46b3a40409d8d53
cites cdi_FETCH-LOGICAL-c5732-9071daea1212fa7dcbf23baad19b71e03e36225337cbd6202d46b3a40409d8d53
container_end_page 894
container_issue 4
container_start_page 887
container_title British journal of pharmacology
container_volume 104
creator Tadipatri, Sreekanth
Heuven‐Nolsen, Dicky
Feniuk, Wasyl
Saxena, Pramod R.
description 1 Using a number of agonist and antagonist compounds, we have attempted to characterize the responses and receptors involved in the effects of 5‐hydroxytryptamine (5‐HT) in the rabbit isolated renal artery. 2 In vessel segments precontracted with the thromboxane‐mimetic agent, U46619 (100 nm), neither 5‐HT (10−8 to 10−4 m) nor 5‐carboxamidotryptamine (5‐CT; 10−8 to 3 × 10−4 m) caused relaxations like those observed with methacholine. Both 5‐HT and 5‐CT further increased the tone of the vessels, with pD2 values of 7.1 and 7.9, respectively. 3 In the absence of U46619, both 5‐HT (10−7 to 3 × 10−3 m) and 5‐CT (10−7 to 10−3 m) contracted the rabbit renal artery, but with reduced potencies. The contractions to 5‐HT were reproducible and the rank order of potency (pD2) of the agonists was: α‐methyl‐5‐HT (5.7), sumatriptan (5.3), 5‐HT (5.1), 8‐hydroxy‐2(di‐n‐propylamino)tetralin (5.0), 5‐CT (4.7) and 5‐methoxytryptamine (4.3). 1‐(2,5‐Dimethoxy‐4‐iodophenyl)‐2‐aminopropane, flesinoxan and RU 24969 elicited either only small contractions or none at all. 4 The contractile effect of 5‐HT was unaffected by MDL 72222 (10−6 m) and metergoline (10−8 and 10−7 m), was weakly antagonized by ketanserin and phentolamine (pKB: 6.6 and 6.8, respectively), but was effectively antagonized by methiothepin (pKB: 8.6). Responses to 5‐CT and sumatriptan were affected by ketanserin, phentolamine and methiothepin similarly to 5‐HT‐induced responses. 5 Ketanserin was ineffective against noradrenaline‐induced contractions, which were antagonized by phentolamine with a pKB of 7.3. The pKB values of phentolamine against 5‐HT, 5‐CT or sumatriptan were about half a log unit lower than against noradrenaline. 6 In vascular preparations treated with cocaine (3 × 10−5 m), the potency (pKB) of phentolamine as an antagonist of the responses to noradrenaline (7.6) and 5‐HT (6.7) did not differ significantly from the values in untreated preparations. However, the difference between the pKB values of phentolamine against the two agonists was now about one log unit. 7 Pretreatment of the vascular strips with 6‐hydroxydopamine (1.5 × 10−3 m) did not significantly affect responses to 5‐HT or 5‐CT, but almost eliminated those to tyramine. Cocaine (3 × 10−5 m) slightly potentiated noradrenaline‐induced contractions, but did not significantly affect those induced by 5‐HT. 8 These data suggest that: (i) 5‐HT receptors mediating vasodilatation are not present in the rabbit renal artery smooth muscle or endot
doi_str_mv 10.1111/j.1476-5381.1991.tb12522.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1908853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72692874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5732-9071daea1212fa7dcbf23baad19b71e03e36225337cbd6202d46b3a40409d8d53</originalsourceid><addsrcrecordid>eNqVUctu1DAUtRCoTAc-ASlCiF2CH0kcs0AtFe1UqgSLsmJhXT_SepSJB9sDnV0_gW_kS3A6oyks8caWzuMe34PQa4Irks-7ZUVq3pYN60hFhCBVUoQ2lFZ3T9DsAD1FM4wxLwnpuufoOMYlxhnkzRE6Im3LaSdm6NvpCMM2ulj4vki3tmh-3_9aXBfBartOPsRiZY2D5MabQvsxBdDJ-TEWbnygB1DKpcJFP0CyJuuyXwEh2bB9gZ71MET7cn_P0dfzT9dni_Lq88Xl2elVqRvOaCkwJwYsEEpoD9xo1VOmAAwRihOLmWUtpQ1jXCvTUkxN3SoGNa6xMJ1p2Bx92PmuNyqn1XaKOch1cCsIW-nByX-R0d3KG_9DEoG7LhvP0du9QfDfNzYmuXJR22GA0fpNlJy2gna8zsT3O6IOPsZg-8MQguVUjVzKaf9y2r-cqpH7auRdFr_6O-ajdNdFxt_scYgahj7AqF080Bpct4JNvz3Z0X66wW7_I4D8-GXx8GR_ADZFrm8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72692874</pqid></control><display><type>article</type><title>Analysis of the 5‐HT receptors mediating contractions in the rabbit isolated renal artery</title><source>PubMed Central</source><creator>Tadipatri, Sreekanth ; Heuven‐Nolsen, Dicky ; Feniuk, Wasyl ; Saxena, Pramod R.</creator><creatorcontrib>Tadipatri, Sreekanth ; Heuven‐Nolsen, Dicky ; Feniuk, Wasyl ; Saxena, Pramod R.</creatorcontrib><description>1 Using a number of agonist and antagonist compounds, we have attempted to characterize the responses and receptors involved in the effects of 5‐hydroxytryptamine (5‐HT) in the rabbit isolated renal artery. 2 In vessel segments precontracted with the thromboxane‐mimetic agent, U46619 (100 nm), neither 5‐HT (10−8 to 10−4 m) nor 5‐carboxamidotryptamine (5‐CT; 10−8 to 3 × 10−4 m) caused relaxations like those observed with methacholine. Both 5‐HT and 5‐CT further increased the tone of the vessels, with pD2 values of 7.1 and 7.9, respectively. 3 In the absence of U46619, both 5‐HT (10−7 to 3 × 10−3 m) and 5‐CT (10−7 to 10−3 m) contracted the rabbit renal artery, but with reduced potencies. The contractions to 5‐HT were reproducible and the rank order of potency (pD2) of the agonists was: α‐methyl‐5‐HT (5.7), sumatriptan (5.3), 5‐HT (5.1), 8‐hydroxy‐2(di‐n‐propylamino)tetralin (5.0), 5‐CT (4.7) and 5‐methoxytryptamine (4.3). 1‐(2,5‐Dimethoxy‐4‐iodophenyl)‐2‐aminopropane, flesinoxan and RU 24969 elicited either only small contractions or none at all. 4 The contractile effect of 5‐HT was unaffected by MDL 72222 (10−6 m) and metergoline (10−8 and 10−7 m), was weakly antagonized by ketanserin and phentolamine (pKB: 6.6 and 6.8, respectively), but was effectively antagonized by methiothepin (pKB: 8.6). Responses to 5‐CT and sumatriptan were affected by ketanserin, phentolamine and methiothepin similarly to 5‐HT‐induced responses. 5 Ketanserin was ineffective against noradrenaline‐induced contractions, which were antagonized by phentolamine with a pKB of 7.3. The pKB values of phentolamine against 5‐HT, 5‐CT or sumatriptan were about half a log unit lower than against noradrenaline. 6 In vascular preparations treated with cocaine (3 × 10−5 m), the potency (pKB) of phentolamine as an antagonist of the responses to noradrenaline (7.6) and 5‐HT (6.7) did not differ significantly from the values in untreated preparations. However, the difference between the pKB values of phentolamine against the two agonists was now about one log unit. 7 Pretreatment of the vascular strips with 6‐hydroxydopamine (1.5 × 10−3 m) did not significantly affect responses to 5‐HT or 5‐CT, but almost eliminated those to tyramine. Cocaine (3 × 10−5 m) slightly potentiated noradrenaline‐induced contractions, but did not significantly affect those induced by 5‐HT. 8 These data suggest that: (i) 5‐HT receptors mediating vasodilatation are not present in the rabbit renal artery smooth muscle or endothelium; (ii) the contractile effect of 5‐HT does not involve the release of noradrenaline from sympathetic nerve stores; (iii) the 5‐HT receptor in the rabbit renal artery is not of the 5‐HT2, 5‐HT3 or 5‐HT4 type. The pharmacological properties of this receptor most closely resemble those described for the heterogeneous 5‐HT1‐like category.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1991.tb12522.x</identifier><identifier>PMID: 1667289</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid ; 5‐carboxamidotryptamine ; 5‐Hydroxytryptamine ; 5‐hydroxytryptamine receptors ; 8-Hydroxy-2-(di-n-propylamino)tetralin ; Animals ; Biological and medical sciences ; Blood vessels and receptors ; Cocaine - pharmacology ; Fundamental and applied biological sciences. Psychology ; In Vitro Techniques ; Indoles - pharmacology ; ketanserin ; Ketanserin - pharmacology ; Muscle Contraction - drug effects ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - physiology ; Norepinephrine - pharmacology ; Oxidopamine - pharmacology ; phentolamine ; Phentolamine - pharmacology ; Prostaglandin Endoperoxides, Synthetic - pharmacology ; rabbit ; Rabbits ; Receptors, Serotonin - drug effects ; Receptors, Serotonin - physiology ; renal artery ; Renal Artery - drug effects ; Renal Artery - physiology ; Serotonin - analogs &amp; derivatives ; Serotonin - pharmacology ; Serotonin Antagonists - pharmacology ; Sulfonamides - pharmacology ; Sumatriptan ; Sympathectomy ; Tetrahydronaphthalenes - pharmacology ; Tyramine - pharmacology ; U46619 interactions ; Vasoconstrictor Agents - pharmacology ; Vasodilation - drug effects ; Vertebrates: cardiovascular system</subject><ispartof>British journal of pharmacology, 1991-12, Vol.104 (4), p.887-894</ispartof><rights>1991 British Pharmacological Society</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5732-9071daea1212fa7dcbf23baad19b71e03e36225337cbd6202d46b3a40409d8d53</citedby><cites>FETCH-LOGICAL-c5732-9071daea1212fa7dcbf23baad19b71e03e36225337cbd6202d46b3a40409d8d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908853/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908853/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5046935$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1667289$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tadipatri, Sreekanth</creatorcontrib><creatorcontrib>Heuven‐Nolsen, Dicky</creatorcontrib><creatorcontrib>Feniuk, Wasyl</creatorcontrib><creatorcontrib>Saxena, Pramod R.</creatorcontrib><title>Analysis of the 5‐HT receptors mediating contractions in the rabbit isolated renal artery</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1 Using a number of agonist and antagonist compounds, we have attempted to characterize the responses and receptors involved in the effects of 5‐hydroxytryptamine (5‐HT) in the rabbit isolated renal artery. 2 In vessel segments precontracted with the thromboxane‐mimetic agent, U46619 (100 nm), neither 5‐HT (10−8 to 10−4 m) nor 5‐carboxamidotryptamine (5‐CT; 10−8 to 3 × 10−4 m) caused relaxations like those observed with methacholine. Both 5‐HT and 5‐CT further increased the tone of the vessels, with pD2 values of 7.1 and 7.9, respectively. 3 In the absence of U46619, both 5‐HT (10−7 to 3 × 10−3 m) and 5‐CT (10−7 to 10−3 m) contracted the rabbit renal artery, but with reduced potencies. The contractions to 5‐HT were reproducible and the rank order of potency (pD2) of the agonists was: α‐methyl‐5‐HT (5.7), sumatriptan (5.3), 5‐HT (5.1), 8‐hydroxy‐2(di‐n‐propylamino)tetralin (5.0), 5‐CT (4.7) and 5‐methoxytryptamine (4.3). 1‐(2,5‐Dimethoxy‐4‐iodophenyl)‐2‐aminopropane, flesinoxan and RU 24969 elicited either only small contractions or none at all. 4 The contractile effect of 5‐HT was unaffected by MDL 72222 (10−6 m) and metergoline (10−8 and 10−7 m), was weakly antagonized by ketanserin and phentolamine (pKB: 6.6 and 6.8, respectively), but was effectively antagonized by methiothepin (pKB: 8.6). Responses to 5‐CT and sumatriptan were affected by ketanserin, phentolamine and methiothepin similarly to 5‐HT‐induced responses. 5 Ketanserin was ineffective against noradrenaline‐induced contractions, which were antagonized by phentolamine with a pKB of 7.3. The pKB values of phentolamine against 5‐HT, 5‐CT or sumatriptan were about half a log unit lower than against noradrenaline. 6 In vascular preparations treated with cocaine (3 × 10−5 m), the potency (pKB) of phentolamine as an antagonist of the responses to noradrenaline (7.6) and 5‐HT (6.7) did not differ significantly from the values in untreated preparations. However, the difference between the pKB values of phentolamine against the two agonists was now about one log unit. 7 Pretreatment of the vascular strips with 6‐hydroxydopamine (1.5 × 10−3 m) did not significantly affect responses to 5‐HT or 5‐CT, but almost eliminated those to tyramine. Cocaine (3 × 10−5 m) slightly potentiated noradrenaline‐induced contractions, but did not significantly affect those induced by 5‐HT. 8 These data suggest that: (i) 5‐HT receptors mediating vasodilatation are not present in the rabbit renal artery smooth muscle or endothelium; (ii) the contractile effect of 5‐HT does not involve the release of noradrenaline from sympathetic nerve stores; (iii) the 5‐HT receptor in the rabbit renal artery is not of the 5‐HT2, 5‐HT3 or 5‐HT4 type. The pharmacological properties of this receptor most closely resemble those described for the heterogeneous 5‐HT1‐like category.</description><subject>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid</subject><subject>5‐carboxamidotryptamine</subject><subject>5‐Hydroxytryptamine</subject><subject>5‐hydroxytryptamine receptors</subject><subject>8-Hydroxy-2-(di-n-propylamino)tetralin</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood vessels and receptors</subject><subject>Cocaine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>In Vitro Techniques</subject><subject>Indoles - pharmacology</subject><subject>ketanserin</subject><subject>Ketanserin - pharmacology</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - physiology</subject><subject>Norepinephrine - pharmacology</subject><subject>Oxidopamine - pharmacology</subject><subject>phentolamine</subject><subject>Phentolamine - pharmacology</subject><subject>Prostaglandin Endoperoxides, Synthetic - pharmacology</subject><subject>rabbit</subject><subject>Rabbits</subject><subject>Receptors, Serotonin - drug effects</subject><subject>Receptors, Serotonin - physiology</subject><subject>renal artery</subject><subject>Renal Artery - drug effects</subject><subject>Renal Artery - physiology</subject><subject>Serotonin - analogs &amp; derivatives</subject><subject>Serotonin - pharmacology</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Sulfonamides - pharmacology</subject><subject>Sumatriptan</subject><subject>Sympathectomy</subject><subject>Tetrahydronaphthalenes - pharmacology</subject><subject>Tyramine - pharmacology</subject><subject>U46619 interactions</subject><subject>Vasoconstrictor Agents - pharmacology</subject><subject>Vasodilation - drug effects</subject><subject>Vertebrates: cardiovascular system</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNqVUctu1DAUtRCoTAc-ASlCiF2CH0kcs0AtFe1UqgSLsmJhXT_SepSJB9sDnV0_gW_kS3A6oyks8caWzuMe34PQa4Irks-7ZUVq3pYN60hFhCBVUoQ2lFZ3T9DsAD1FM4wxLwnpuufoOMYlxhnkzRE6Im3LaSdm6NvpCMM2ulj4vki3tmh-3_9aXBfBartOPsRiZY2D5MabQvsxBdDJ-TEWbnygB1DKpcJFP0CyJuuyXwEh2bB9gZ71MET7cn_P0dfzT9dni_Lq88Xl2elVqRvOaCkwJwYsEEpoD9xo1VOmAAwRihOLmWUtpQ1jXCvTUkxN3SoGNa6xMJ1p2Bx92PmuNyqn1XaKOch1cCsIW-nByX-R0d3KG_9DEoG7LhvP0du9QfDfNzYmuXJR22GA0fpNlJy2gna8zsT3O6IOPsZg-8MQguVUjVzKaf9y2r-cqpH7auRdFr_6O-ajdNdFxt_scYgahj7AqF080Bpct4JNvz3Z0X66wW7_I4D8-GXx8GR_ADZFrm8</recordid><startdate>199112</startdate><enddate>199112</enddate><creator>Tadipatri, Sreekanth</creator><creator>Heuven‐Nolsen, Dicky</creator><creator>Feniuk, Wasyl</creator><creator>Saxena, Pramod R.</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199112</creationdate><title>Analysis of the 5‐HT receptors mediating contractions in the rabbit isolated renal artery</title><author>Tadipatri, Sreekanth ; Heuven‐Nolsen, Dicky ; Feniuk, Wasyl ; Saxena, Pramod R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5732-9071daea1212fa7dcbf23baad19b71e03e36225337cbd6202d46b3a40409d8d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid</topic><topic>5‐carboxamidotryptamine</topic><topic>5‐Hydroxytryptamine</topic><topic>5‐hydroxytryptamine receptors</topic><topic>8-Hydroxy-2-(di-n-propylamino)tetralin</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood vessels and receptors</topic><topic>Cocaine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>In Vitro Techniques</topic><topic>Indoles - pharmacology</topic><topic>ketanserin</topic><topic>Ketanserin - pharmacology</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - physiology</topic><topic>Norepinephrine - pharmacology</topic><topic>Oxidopamine - pharmacology</topic><topic>phentolamine</topic><topic>Phentolamine - pharmacology</topic><topic>Prostaglandin Endoperoxides, Synthetic - pharmacology</topic><topic>rabbit</topic><topic>Rabbits</topic><topic>Receptors, Serotonin - drug effects</topic><topic>Receptors, Serotonin - physiology</topic><topic>renal artery</topic><topic>Renal Artery - drug effects</topic><topic>Renal Artery - physiology</topic><topic>Serotonin - analogs &amp; derivatives</topic><topic>Serotonin - pharmacology</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Sulfonamides - pharmacology</topic><topic>Sumatriptan</topic><topic>Sympathectomy</topic><topic>Tetrahydronaphthalenes - pharmacology</topic><topic>Tyramine - pharmacology</topic><topic>U46619 interactions</topic><topic>Vasoconstrictor Agents - pharmacology</topic><topic>Vasodilation - drug effects</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tadipatri, Sreekanth</creatorcontrib><creatorcontrib>Heuven‐Nolsen, Dicky</creatorcontrib><creatorcontrib>Feniuk, Wasyl</creatorcontrib><creatorcontrib>Saxena, Pramod R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tadipatri, Sreekanth</au><au>Heuven‐Nolsen, Dicky</au><au>Feniuk, Wasyl</au><au>Saxena, Pramod R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of the 5‐HT receptors mediating contractions in the rabbit isolated renal artery</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1991-12</date><risdate>1991</risdate><volume>104</volume><issue>4</issue><spage>887</spage><epage>894</epage><pages>887-894</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1 Using a number of agonist and antagonist compounds, we have attempted to characterize the responses and receptors involved in the effects of 5‐hydroxytryptamine (5‐HT) in the rabbit isolated renal artery. 2 In vessel segments precontracted with the thromboxane‐mimetic agent, U46619 (100 nm), neither 5‐HT (10−8 to 10−4 m) nor 5‐carboxamidotryptamine (5‐CT; 10−8 to 3 × 10−4 m) caused relaxations like those observed with methacholine. Both 5‐HT and 5‐CT further increased the tone of the vessels, with pD2 values of 7.1 and 7.9, respectively. 3 In the absence of U46619, both 5‐HT (10−7 to 3 × 10−3 m) and 5‐CT (10−7 to 10−3 m) contracted the rabbit renal artery, but with reduced potencies. The contractions to 5‐HT were reproducible and the rank order of potency (pD2) of the agonists was: α‐methyl‐5‐HT (5.7), sumatriptan (5.3), 5‐HT (5.1), 8‐hydroxy‐2(di‐n‐propylamino)tetralin (5.0), 5‐CT (4.7) and 5‐methoxytryptamine (4.3). 1‐(2,5‐Dimethoxy‐4‐iodophenyl)‐2‐aminopropane, flesinoxan and RU 24969 elicited either only small contractions or none at all. 4 The contractile effect of 5‐HT was unaffected by MDL 72222 (10−6 m) and metergoline (10−8 and 10−7 m), was weakly antagonized by ketanserin and phentolamine (pKB: 6.6 and 6.8, respectively), but was effectively antagonized by methiothepin (pKB: 8.6). Responses to 5‐CT and sumatriptan were affected by ketanserin, phentolamine and methiothepin similarly to 5‐HT‐induced responses. 5 Ketanserin was ineffective against noradrenaline‐induced contractions, which were antagonized by phentolamine with a pKB of 7.3. The pKB values of phentolamine against 5‐HT, 5‐CT or sumatriptan were about half a log unit lower than against noradrenaline. 6 In vascular preparations treated with cocaine (3 × 10−5 m), the potency (pKB) of phentolamine as an antagonist of the responses to noradrenaline (7.6) and 5‐HT (6.7) did not differ significantly from the values in untreated preparations. However, the difference between the pKB values of phentolamine against the two agonists was now about one log unit. 7 Pretreatment of the vascular strips with 6‐hydroxydopamine (1.5 × 10−3 m) did not significantly affect responses to 5‐HT or 5‐CT, but almost eliminated those to tyramine. Cocaine (3 × 10−5 m) slightly potentiated noradrenaline‐induced contractions, but did not significantly affect those induced by 5‐HT. 8 These data suggest that: (i) 5‐HT receptors mediating vasodilatation are not present in the rabbit renal artery smooth muscle or endothelium; (ii) the contractile effect of 5‐HT does not involve the release of noradrenaline from sympathetic nerve stores; (iii) the 5‐HT receptor in the rabbit renal artery is not of the 5‐HT2, 5‐HT3 or 5‐HT4 type. The pharmacological properties of this receptor most closely resemble those described for the heterogeneous 5‐HT1‐like category.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>1667289</pmid><doi>10.1111/j.1476-5381.1991.tb12522.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 1991-12, Vol.104 (4), p.887-894
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1908853
source PubMed Central
subjects 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
5‐carboxamidotryptamine
5‐Hydroxytryptamine
5‐hydroxytryptamine receptors
8-Hydroxy-2-(di-n-propylamino)tetralin
Animals
Biological and medical sciences
Blood vessels and receptors
Cocaine - pharmacology
Fundamental and applied biological sciences. Psychology
In Vitro Techniques
Indoles - pharmacology
ketanserin
Ketanserin - pharmacology
Muscle Contraction - drug effects
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - physiology
Norepinephrine - pharmacology
Oxidopamine - pharmacology
phentolamine
Phentolamine - pharmacology
Prostaglandin Endoperoxides, Synthetic - pharmacology
rabbit
Rabbits
Receptors, Serotonin - drug effects
Receptors, Serotonin - physiology
renal artery
Renal Artery - drug effects
Renal Artery - physiology
Serotonin - analogs & derivatives
Serotonin - pharmacology
Serotonin Antagonists - pharmacology
Sulfonamides - pharmacology
Sumatriptan
Sympathectomy
Tetrahydronaphthalenes - pharmacology
Tyramine - pharmacology
U46619 interactions
Vasoconstrictor Agents - pharmacology
Vasodilation - drug effects
Vertebrates: cardiovascular system
title Analysis of the 5‐HT receptors mediating contractions in the rabbit isolated renal artery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T04%3A00%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20the%205%E2%80%90HT%20receptors%20mediating%20contractions%20in%20the%20rabbit%20isolated%20renal%20artery&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Tadipatri,%20Sreekanth&rft.date=1991-12&rft.volume=104&rft.issue=4&rft.spage=887&rft.epage=894&rft.pages=887-894&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.1991.tb12522.x&rft_dat=%3Cproquest_pubme%3E72692874%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5732-9071daea1212fa7dcbf23baad19b71e03e36225337cbd6202d46b3a40409d8d53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72692874&rft_id=info:pmid/1667289&rfr_iscdi=true